(Q48560324)

12 February 2018

title

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. (English)

1 reference

12 February 2018

1 reference

6

1 reference

12 February 2018

Niki Karavitaki

object named as

Niki Karavitaki

1

0 references

John A H Wass

8

object named as

John A H Wass

1 reference

12 February 2018

author name string

Justin T Warner

2

1 reference

12 February 2018

Anne Marland

3

1 reference

12 February 2018

Brian Shine

4

1 reference

12 February 2018

Fiona Ryan

5

1 reference

12 February 2018

Helen E Turner

7

1 reference

12 February 2018

publication date

1 May 2006

1 reference

12 February 2018

published in

Clinical Endocrinology

1 reference

12 February 2018

volume

64

1 reference

12 February 2018

issue

5

1 reference

12 February 2018

page(s)

556-560

1 reference

12 February 2018

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Correlation of clinical and pathological features in surgically treated craniopharyngiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Long-term experience with GH replacement therapy: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Growth hormone treatment induces mammary gland hyperplasia in aging primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Cancer risk following growth hormone use in childhood: implications for current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Long-term outcomes for surgically resected craniopharyngiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

20-year experience in childhood craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Craniopharyngioma--a long-term results following limited surgery and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

CRANIOPHARYNGIOMA RECURRENCE AND GROWTH HORMONE THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Adverse events during growth hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02508.X

10.1111/J.1365-2265.2006.02508.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018